TipRanks
OncoZenge AB (DE:8LY)
FRANKFURT:8LY

Compare OncoZenge AB (8LY) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
OncoZenge AB
€0.59
€7.79M
-1.83
-30.62%
―
Oncopeptides AB
kr1.65
kr803.14M
-2.70
-57.48%
―
Isofol Medical AB
kr0.72
kr239.09M
-3.66
-3.74%
―
Elicera Therapeutics AB
kr5.35
kr190.53M
-8.07
-62.91%
―
Immunicum AB
kr5.77
kr393.29M
-3.46
-3.13%
―
Cantargia AB
kr4.07
kr397.26M
2.07
-46.83%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:8LY
OncoZenge AB
0.29
-0.15
-34.09%
SE:ONCO
Oncopeptides AB
2.11
-3.54
-62.67%
SE:ISOFOL
Isofol Medical AB
0.75
>-0.01
-1.06%
SE:ELIC
Elicera Therapeutics AB
2.86
-3.92
-57.83%
SE:IMMU
Immunicum AB
6.20
-0.07
-1.12%
SE:CANTA
Cantargia AB
1.41
-1.38
-49.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts